Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP979978.RAnRQFE4afCBvkvpnAuVsgiL-MzHS6nWmNulpjDW9uesg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP979978.RAnRQFE4afCBvkvpnAuVsgiL-MzHS6nWmNulpjDW9uesg130_assertion type Assertion NP979978.RAnRQFE4afCBvkvpnAuVsgiL-MzHS6nWmNulpjDW9uesg130_head.
- NP979978.RAnRQFE4afCBvkvpnAuVsgiL-MzHS6nWmNulpjDW9uesg130_assertion description "[In addition, Survivin-VISA-hEndoyCD plus 5-FC showed strong synergistic effects in combination with cisplatin in ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979978.RAnRQFE4afCBvkvpnAuVsgiL-MzHS6nWmNulpjDW9uesg130_provenance.
- NP979978.RAnRQFE4afCBvkvpnAuVsgiL-MzHS6nWmNulpjDW9uesg130_assertion evidence source_evidence_literature NP979978.RAnRQFE4afCBvkvpnAuVsgiL-MzHS6nWmNulpjDW9uesg130_provenance.
- NP979978.RAnRQFE4afCBvkvpnAuVsgiL-MzHS6nWmNulpjDW9uesg130_assertion SIO_000772 22562248 NP979978.RAnRQFE4afCBvkvpnAuVsgiL-MzHS6nWmNulpjDW9uesg130_provenance.
- NP979978.RAnRQFE4afCBvkvpnAuVsgiL-MzHS6nWmNulpjDW9uesg130_assertion wasDerivedFrom befree-2016 NP979978.RAnRQFE4afCBvkvpnAuVsgiL-MzHS6nWmNulpjDW9uesg130_provenance.
- NP979978.RAnRQFE4afCBvkvpnAuVsgiL-MzHS6nWmNulpjDW9uesg130_assertion wasGeneratedBy ECO_0000203 NP979978.RAnRQFE4afCBvkvpnAuVsgiL-MzHS6nWmNulpjDW9uesg130_provenance.